Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Drug Delivery Trends examines a drift in the pharmaceutical field across the wide range of dosage forms, drug delivery systems (micro and nanoparticulate), at the regulatory front and on new types of therapies in the market. This volume additionally covers the challenges on drug delivery systems in terms of preclinical and current ways of determining quality and the options to solve the challenges associated with this. Most small-medium scale industries and academics struggle with initial regulatory challenges so a detailed discussion on regulatory trend covers the necessary basic understanding of regulatory procedures and provides the required guidance.
The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers.
Expectations and Realities of Multifunctional Drug Delivery Systems connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it as a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about drug delivery systems.
Encompasses trends in drug delivery systems and selected dosage forms
Illustrates regulatory, preclinical and quality principles
Contains in-depth investigation of upcoming types of drug delivery systems
Other volumes in the Expectations and Realities of Multifunctional Drug Delivery Systems book series:
Nanopharmaceuticals, Volume 1, 9780128177785
Delivery of Drugs, Volume 2, 9780128177761
Drug Delivery Aspects, Volume 4, 9780128212226
Pharmaceutical Scientists in academia and industry; pharmacologists; regulatory experts; bioengineers
- Bioactive hybrid nanowires: a new in trend for site-speciﬁc drug delivery and targeting
A.R. FERNANDES, J. DIAS-FERREIRA, M.C. TEIXEIRA, A.A.M. SHIMOJO, PATRÍCIA SEVERINO, A.M. SILVA, RANJITA SHEGOKAR, AND ELIANA B. SOUTO
2. Opportunities and challenges of 3D-printed pharmaceutical dosage forms
ADAM PROCOPIO AND DIVYA TEWARI
3. Marketing authorization and licensing of medicinal products in EU: Regulatory aspects
4. Clinical considerations on micro- and nanodrug delivery systems
PRAMIL TIWARI, VIVEK RANJAN SINHA, AND RANDEEP KAUR
5. Nanoparticulate treatments for oral delivery
ROHIT C. GHAN
6. Pharmaceutical mini-tablets: a revived trend
7. Liquid crystalline drug delivery systems
LUCIANA NALONE, CONRADO MARQUES, SALVANA COSTA, ELIANA B. SOUTO, AND PATRÍCIA SEVERINO
8. Amorphous drug stabilization using mesoporous materials
DANILLO F.M.C. VELOSO, MATTHIAS M. KNOPP, AND KORBINIAN L€OBMANN
9. “Quality” of pharmaceutical products for human usedunderlying concepts and required practices
SAEED A. QURESHI
10. Optimizing intraperitoneal drug delivery: pressurized intraperitoneal aerosol chemotherapy (PIPAC)
M.A. REYMOND AND A. K€ONIGSRAINER
11. Upscaling and GMP production of pharmaceutical drug delivery systems
NAZENDE G€UNDAY T€URELI AND AKIF EMRE T€URELI
- No. of pages:
- © Elsevier 2020
- 4th March 2020
- Paperback ISBN:
- eBook ISBN:
Dr. Ranjita Shegokar holds a PhD degree in Pharmaceutical Technology from the SNDT University, India, and has been postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at Free University of Berlin, Germany. Since last 8 years she is working in the pharmaceutical industry in various technical/R&D roles. Currently, she serves as Director of Pharma Business Unit at Capnomed GmbH, Germany. She has authored many research articles, book chapters, and presented several research papers in conferences. She has filed multiple patent application in area of drug delivery and drug targeting. She received several national and international awards for her research. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions and role of excipients in delivery systems.
Director, Pharma Business Unit, Capnomed GmbH, Germany
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.